News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
57,345 Results
Type
Article (3646)
Company Profile (13)
Press Release (53686)
Section
Business (21821)
Career Advice (69)
Deals (3790)
Drug Delivery (9)
Drug Development (4389)
Employer Resources (13)
FDA (924)
Job Trends (1118)
News (29930)
Policy (1409)
Tag
Academia (265)
Africa (68)
Alliances (5261)
Alzheimer's disease (105)
Approvals (923)
Arizona (9)
Artificial intelligence (13)
Asia (4010)
Australia (478)
Bankruptcy (33)
Best Places to Work (796)
Biotechnology (12)
C2C Services and Suppliers (6362)
California (187)
Canada (220)
Cancer (29)
Career advice (63)
Cell therapy (11)
China (13)
Clinical research (3258)
Collaboration (12)
Colorado (7)
Connecticut (9)
COVID-19 (148)
Cystic fibrosis (12)
Data (11)
Diabetes (9)
Diagnostics (598)
Drug pricing (8)
Earnings (4370)
Employer resources (11)
Europe (8151)
Events (5346)
Executive appointments (21)
FDA (937)
Florida (10)
Funding (61)
Gene editing (5)
Gene therapy (8)
GLP-1 (53)
Government (135)
Healthcare (1312)
Hotbed/Location (38359)
Illinois (25)
Indiana (16)
Infectious disease (150)
Inflammatory bowel disease (12)
Interviews (5)
IPO (1745)
IRA (6)
Job creations (319)
Job search strategy (61)
Kansas (7)
Layoffs (32)
Legal (272)
Lung cancer (11)
Manufacturing (5)
Maryland (16)
Massachusetts (111)
Medical device (1255)
Medtech (1257)
Mergers & acquisitions (2033)
Metabolic disorders (22)
Minnesota (6)
Neuroscience (115)
New Jersey (21)
New York (27)
NextGen Class of 2024 (975)
Non-profit (322)
North Carolina (26)
Northern California (99)
Obesity (14)
Ohio (17)
Opinion (45)
Patents (6)
Pennsylvania (18)
People (8613)
Phase I (1058)
Phase II (1481)
Phase III (976)
Pipeline (6)
Policy (9)
Postmarket research (127)
Preclinical (587)
Press Release (7)
Rare diseases (17)
Real estate (582)
Regulatory (1034)
Research institute (194)
Resumes & cover letters (9)
Series A (21)
Series B (6)
South America (102)
Southern California (61)
Startups (2165)
Texas (18)
United States (569)
Vaccines (13)
Venture capitalists (9)
Weight loss (7)
Date
Today (13)
Last 7 days (71)
Last 30 days (208)
Last 365 days (3275)
2024 (2289)
2023 (3240)
2022 (5699)
2021 (5106)
2020 (4885)
2019 (4479)
2018 (3598)
2017 (3157)
2016 (2637)
2015 (3022)
2014 (2202)
2013 (1818)
2012 (1920)
2011 (2140)
2010 (2234)
57,345 Results for "atlas venture".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Singleron Biotechnologies partners with the Human Cell Atlas (HCA) to enhance access to single cell analysis globally
Singleron Biotechnologies announced a partnership with the Human Cell Atlas (HCA) to help accelerate the adoption of single cell sequencing globally.
June 18, 2024
·
3 min read
Pharm Country
Biomolecular Atlas for Bone Marrow to Offer Unprecedented Window into Blood Production
Researchers at Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania revealed a powerful new bone marrow atlas that will offer the public a first-of-its-kind visual passport into the spectrum of healthy and diseased blood production.
May 6, 2024
·
5 min read
Startups
BridgeBio Launches GondolaBio With $300M, Transfers Programs to Joint Venture
With the help of third-party investors, the new venture will focus on three genetic and rare diseases: tuberous sclerosis complex, erythropoietic protoporphyria and alpha-A1 antitrypsin deficiency.
August 22, 2024
·
2 min read
·
Tristan Manalac
Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program : Eleventh tranche fully issued and paid-up
Oxurion NV, a biopharmaceutical company based in Leuven, communicates it has received an aggregate amount of EUR 450,000 in the framework of the Atlas Funding Program.
April 10, 2024
·
1 min read
Press Releases
Altius Bioventures Launches The CGT Industry Atlas, Mapping out the Cell and Gene Therapy Technology Innovation Landscape
September 11, 2024
·
2 min read
Press Releases
New “Atlas” of Human Heart Valve Development May Guide Next-Gen Therapies
July 31, 2024
·
5 min read
Oxurion Receives EUR 300,000 in the framework of the Atlas Funding Program Tenth tranche fully issued and paid-up
Oxurion NV communicates it has received an aggregate amount of EUR 300,000 in the framework of the Atlas Funding Program.
March 5, 2024
·
1 min read
Press Releases
Somite Therapeutics Announces Round Extension with Astellas Venture Management and Montage Ventures Joining as Board Observers
September 3, 2024
·
3 min read
Pharm Country
JOGO Health Closes $5.5M in Round Led by Hourglass Ventures, Extends Investment Opportunity for Public to Invest Alongside Mayo Clinic Ventures
JOGO Health, a medtech company treating chronic pain and neuromuscular disorders, announced it has closed over $5.5 million in an investment round led by Hourglass Ventures.
June 18, 2024
·
2 min read
Business
AbCellera and Atlas Venture Collaborate to Empower the Development of Impactful Medicines for Patients
AbCellera (Nasdaq: ABCL) and Atlas Venture announced a multi-target partnership to discover therapeutic antibodies for up to three drug targets that can be developed and commercialized by a stealth-stage Atlas-backed company.
August 3, 2022
·
4 min read
1 of 5,735
Next
